• Login
    • Advanced search
    • Title
    • Channel
    • Module
  • Home
  • Industry
    • Financial Institutions and Insurance

      • Financial Institutions
      • Insurance
    •  

      • Aerospace, Defense, and Government Services
      • Automotive and Mobility 
      • Consumer
      • Diversified Industrials
      • Education
      • Energy and Natural Resources
      • Life Sciences and Health Care
      • Real Estate
      • Sports, Media & Entertainment
      • Technology & Telecoms
      • Transport & Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Blockchain
      • Business Restructuring and Insolvency
      • Debt Capital Markets
      • Leveraged and Acquisition Finance
      • Pensions
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health Law
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      •  
  • Resources
  • Engage Premium
  • Login
  • Register
Hogan Lovells Engage 5.4.6
      • Title
      • Channel
      • Module
    • Hit ENTER to search in content
    • Advanced search
    • Login
  • Home
  • Industry
    • Financial Institutions and Insurance

      • Financial Institutions
      • Insurance
    •  

      • Aerospace, Defense, and Government Services
      • Automotive and Mobility 
      • Consumer
      • Diversified Industrials
      • Education
      • Energy and Natural Resources
      • Life Sciences and Health Care
      • Real Estate
      • Sports, Media & Entertainment
      • Technology & Telecoms
      • Transport & Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Blockchain
      • Business Restructuring and Insolvency
      • Debt Capital Markets
      • Leveraged and Acquisition Finance
      • Pensions
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health Law
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      •  
  • Resources
  • Engage Premium
  • Login
  • Register
  1. News
  2. Medical devices in the EU - Update on EUDAMED database: The first module is here!

Medical devices in the EU - Update on EUDAMED database: The first module is here!

12 November 2020
    • Share by email
    • Share on
    • Twitter
    • LinkedIn
    • Get link
    • Get QR Code
    • Download
    • Print

The first module of the European database on medical devices, EUDAMED, also referred to as the Actor registration module, will be made available to EU Member States and economic operators on 1 December 2020.

Index
  1. How does this Actor registration module work?
  2. Time for action?

Currently, EUDAMED is used for the exchange of information between EU Member States and the European Commission. However, with the entry in force of the Medical Devices Regulation (MDR) in 2021 and the In Vitro Diagnostic Medical Devices Regulation (IVDR) in 2022, a new version of EUDAMED is introduced.

The new version of EUDAMED is a multipurpose system that contains information about medical devices, supervising entities and economic operators (“Actors”). The new EUDAMED will also be open to the public.

More specific, the new version of EUDAMED will consist of a public site and the following six interconnected modules:

  • Actor and user registration and management
  • UDI database and registration of devices
  • Certificates and Notified Bodies
  • Clinical Investigation and performance studies
  • Vigilance and post-market surveillance
  • Market surveillance

With this new system, the European Commission expects to improve transparency and coordination of information regarding medical devices available on the EU market.

How does this Actor registration module work?

The Actor registration module enables economic operators – EU and non-EU manufacturers, authorised representatives, system/procedure pack producers and importers - to submit, by means of an Actor registration request, the information necessary to obtain a single registration number (SRN). The SRN guarantees a EU-wide unique identification for economic operators. Following the assessment and approval of the request by the concerned national competent authority, EUDAMED generates the SRN of the economic operator to the national competent authority and transfers it to the requesting economic operator. An economic operator has to obtain a separate SRN for each Actor role it performs.

For non-EU manufacturers, its authorised representative verifies the registration request before passing it to the national competent authority for assessment.

In the process of registration, every Actor appoints a person that manages “Actor data” and “Actor notification email addresses” and that has the power to accept request from others within Actor’s organization to get access to EUDAMED. This person is called the first Local Actor Administrator (“LAA”). The European Commission strongly recommends having at least two LAAs to avoid the situation in which first LAA is not able to respond to user access requests resulting in no one being able to access EUDAMED.

Time for action?

Even though the Actor registration module will be made available on 1 December 2020 and the Medical Device Coordination Group strongly encourages the use of the Actor registration module by all relevant Actors on their territories,[1] using the module is not obligatory as of 1 December 2020 nor when the MDR enters into force on the 26st of May 2021. The MDR provides that, since EUDAMED will not be fully functional on 26 May 2021, the obligations and requirements that relate to EUDAMED shall apply six months after the date of publication of the European Commission’s notice thereto in the Official Journal of the European Union.

In conclusion, use of EUDAMED is encouraged, but it remains to be seen when using EUDAMED becomes mandatory for economic operators. Therefore, no immediate action is required as of 1 December 2020. It is, however, possible that Member States will require Actors to register themselves using the Actor registration module well before the other modules are made available.[2]

 

Authored by Hein van den Bos, Karen Jelsma, and Wouter van Beek

 


[1]               Medical Device Coordination Group, ‘MDCG Position Paper on the use of the EUDAMED actor registration module and of the Single Registration Number (SRN) in the Member States’, August 2015.

[2]               The Dutch Minister of Healthcare has stated that Member States will make use of the Actor registration module on a voluntary basis (Dutch Minister of Healthcare T. van Ark, ‘Hulpmiddelenbeleid in de gezondheidszorg; Brief regering; Voortgang medisch hulpmiddelenbeleid’, 9 October 2020, p. 12).

Contacts
Hein van den Bos
Partner
Amsterdam
Karen Jelsma
Senior Associate
Amsterdam
Wouter van Beek
Associate
Amsterdam
Index
  1. How does this Actor registration module work?
  2. Time for action?
Keywords eudamed, actor registration
Languages English
Topics Clinical Studies/Product Design and Development, Conformity Assessment Procedure/CE Mark, In Vitro Diagnostics, MDR/IVDR, Postmarket Performance, Premarket Strategy, Submissions, and Review, Regulatory Inspections and QSR/ISO 13485
Countries Belgium, Croatia, France, Germany, Hungary, Italy, Luxembourg, Netherlands, Poland, Russia, Spain, United Kingdom
Delete Comment ?

Are you sure want to delete comment ?

Get link
Embed
Share by email
Get QR Code

Scan this QR Code to share this content